ASAH1 variant causing a mild SMA phenotype with no myoclonic epilepsy: a clinical, biochemical and molecular study

ASAH1 gene encodes for acid ceramidase that is involved in the degradation of ceramide into sphingosine and free fatty acids within lysosomes. ASAH1 variants cause both the severe and early-onset Farber disease and rare cases of spinal muscular atrophy (SMA) with progressive myoclonic epilepsy (SMA-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Hum Genet
Autors principals: Filosto, Massimiliano, Aureli, Massimo, Castellotti, Barbara, Rinaldi, Fabrizio, Schiumarini, Domitilla, Valsecchi, Manuela, Lualdi, Susanna, Mazzotti, Raffaella, Pensato, Viviana, Rota, Silvia, Gellera, Cinzia, Filocamo, Mirella, Padovani, Alessandro
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5110045/
https://ncbi.nlm.nih.gov/pubmed/27026573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ejhg.2016.28
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars